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Introduction 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) are a well-established class of drugs used widely in the treatment of hypercholesterolemia due to their tolerability, proven efficacy and convenient administration. Except for simvastatin and lovastatin, all current statins are administered as the pharmacologically active hydroxy acid form. Simvastatin and lovastatin are administered as inactive lactones, which, upon hydrolysis to their respective hydroxy acids (SVA and LVA), serve as potent competitive inhibitors of HMG-CoA reductase, the rate-limiting enzyme in de novo cholesterol biosynthesis (Duggan and Vickers,
7 assessed by the activity of their respective marker enzymes: catalase for peroxisomes (Baudhuin et al., 1964) , cytochrome c oxidase for mitochondria (Sellinger et al., 1960) , lactate dehydrogenase for cytosol (Volkl and Fahimi, 1985) and NADPH-cytochrome c reductase for microsomes (Beaufay et al., 1974) .
In Vitro Metabolism. Incubations of SVA (100 µM) with mouse liver subcellular fractions (1.5 mg/mL) were carried out in triplicate in 150 mM Tris-HCl buffer (pH 8.0) containing 0.05% Triton X-100, 1.2 mM CoASH, 10 mM MgCl 2 , and 5 mM ATP in a final volume of 0.2 mL. After a 3-min preincubation, reactions were initiated by addition of ATP and incubated for up to 60 min at 37°C. The reactions were terminated at appropriate time intervals by addition of 120 µL of ice cold acetonitrile.
After centrifugation at 10,000 g for 10 min, the supernatant was analyzed immediately by HPLC or LC-MS with an autosampler set at 5°C to minimize any degradation that might have occurred during the sample handling and analysis. Preliminary stability studies showed that SVA-S-acyl coenzyme A (SVA-CoA) and its subsequent metabolites were stable under the condition described above. Control experiments included incubation mixtures with one or more components missing.
Incubations with [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-palmitic acid (50 µM) and [1-For isolation and purification of metabolites of SVA, large scale incubations of SVA (500 µM) were carried out with mouse liver microsomes (1.5 mg/mL), CoASH (1.2 mM) and ATP (5 mM) for 40 min in a final volume of 12 mL for the isolation of SVACoA and P1-S-acyl coenzyme A (P1-CoA) or for 3 hr in a final volume of 60 mL for M1.
The incubation mixtures were terminated with half a volume of acetonitrile and loaded onto C 18 solid phase extraction cartridges (Oasis HLB SPE cartridge, Waters Corporation, Milford, MA), which were pre-equilibrated with water and acetonitrile. The acyl-CoA thioesters-containing fractions were eluted with 70% acetonitrile, while M1-containing fraction was eluted with 90% acetonitrile. The resulting solid phase eluates were evaporated to dryness, reconstituted in 5-10 mL of the mobile phase (20% acetonitrile in 10 mM ammonium acetate buffer, pH = 7) and isolated by preparative HPLC as described below. The purified metabolites were characterized by NMR spectroscopy.
Analytical Methods. SVA and its metabolites were analyzed using published HPLC methods with some modifications (Prueksaritanont et al., 1999) . In brief, samples held in an autosampler (set at 5°C) were chromatographed on a C 18 Zorbax column (150 x 4.6 mm, 5 µm; Agilent Technologies, Foster City, CA) with a linear gradient of acetonitrile and 10 mM ammonium acetate (pH 7). The eluates were monitored by UV absorption at 240 nm and 260 nm. Due to the unavailability of authentic standards for SVA-CoA and P1-CoA , the concentrations of these metabolites in the in vitro incubation mixtures were estimated using standard curves for PA-CoA at 260 nm, assuming similar extinction coefficients between SVA-CoA (or P1-CoA) and PA-CoA. Evidence that This article has not been copyedited and formatted. The final version may differ from this version. supports the assumption includes the observations that SVA, P1 and palmitic acid all had minimal UV absorption at 260 nm, whereas the corresponding acyl-CoA thioesters and free CoASH exhibited maximal UV absorption at 260 nm. In addition, PA-CoA was selected because of its similar HPLC retention time to SVA-CoA and P1-CoA under the HPLC conditions described above. Quantification of P1 and M1 in the in vitro incubations was accomplished using standard curves for SVA and simvastatin, respectively, assuming identical extraction recoveries and extinction coefficients at their maximal UV absorption at 240 nm. Series 200 micro pumps and an autosampler set at 5°C. LC-MS and LC-MS/MS experiments were carried out using electrospray ionization in the negative ion mode (for SVA, P1, SVA-CoA , and P1-CoA ) or positive ion mode (for lactones: simvastatin and M1). The electrospray ionization voltage was set at 3.5 kV with the heated capillary temperature held at 175°C. A C 18 Zorbax column (150 x 4.6 mm, 5 µm; Agilent Technologies, Foster City, CA) was used for chromatographic separation and was eluted at 1.0 mL/min with a gradient of 10 mM ammonium acetate (pH 7) in water with 10% methanol (A) and 90% acetonitrile in water (B). The initial mobile phase consisted of 15% B, which remained unchanged for 5 min, and increased linearly to 70% B over 22 min, then to 90% over 1 min, and held for 5 min. One fifth of the flow was directed into the mass spectrometer, and the remainder was used for UV detection at 240 nm.
Accurate mass measurements were conducted on a Micromass Q-TOF (quadrupole time-of-flight) II mass spectrometer (Waters, Milford, MA) operated in the positive electrospray ionization mode with a LockSpray reference sprayer. The source and desolvation gas temperatures were set at 80°C and 180°C, respectively. The capillary voltage, cone voltage and collision energies were 2.5kV, 25 V and 15V, respectively. The instrument was calibrated by infusing aqueous 0.01% phosphoric acid solution through a syringe pump at 5 µL/min prior to the experiment. The same calibration solution was used as lock mass in the sample analysis. The chromatographic conditions used in Q-TOF experiments were the same as described in LCQ section.
NMR studies were performed at 10°C for CoASH and acyl-CoA thioesters, and at 25 °C for the SVA, simvastatin, and M1 samples. All NMR data were collected either on a 500 or 600 MHz spectrometer (Varian Inc., Palo Alto, CA) both equipped with a 5 mm This article has not been copyedited and formatted. The final version may differ from this version. correlation (a select expansion of the spectrum displayed in Figure 4 ) was observed from both methylene protons 3 and a' to the carbonyl carbon 2 (at 197.9 ppm) in the SVA heptanoic acid side chain. Therefore, the combined NMR data showed that the sulfur of the CoASH was conjugated to the acyl carbon 2 of the heptanoic acid side chain in SVA.
The identification of P1-CoA was based on UV, MS, MS/MS, and NMR spectra. Alkene carbons 3 and 4 in the P1 moiety appeared at δ H 6.22 ppm / δ C 129.9 ppm and δ H 6.90 ppm / δ C 142.6 ppm, respectively ( Table 1 ). The β -methylene group, labeled a', of the mercaptoethylamine subunit in CoASH appeared at δ H 3.04 ppm / δ C 27.6 ppm ( Table   1) Table 2 , which confirmed the fragmentation pathway proposed in Figure 5 . Therefore, high resolution MS data strongly suggested that simvastatin and M1 were positional isomers. The NMR data on M1 was
This article has not been copyedited and formatted. The final version may differ from this version. Comparing the two 1D 1 H NMR spectra, the spectral changes were observed for protons in the six-membered lactone ring. The CHOH methine protons, labeled 4 and 6, appeared at 4.24 and 4.61 ppm, respectively, in simvastatin (Table 1 ). In contrast, H4 and H6 were overlapped and appeared at 4.19 ppm in the M1 spectrum ( Table 1 ). The methine carbons at 4 and 6 were resolved in the 2D 1 H-13 C one-bond correlation spectrum of M1 at 62.8 ppm and 77.8 ppm, respectively (not shown).
Metabolism of SVA in mouse liver subcellular fractions. Time-dependent studies with mouse liver S0.6 showed that formation of SVA-CoA and P1-CoA increased rapidly during the first 10-20 min incubations and then decreased steadily thereafter, whereas formation of P1, M1, and simvastatin appeared to increase gradually with incubation time ( Figure 6A ). In addition to mouse liver S0.6, CoASH-dependent metabolism of SVA was also observed in incubations with other mouse liver subcellular fractions, including mitochondria (MT-H and MT-L) and microsomes ( Figure 7C ). The identities and purities of these subcellular fractions were confirmed by marker enzyme analysis (Table 3) . Among all the mouse subcellular fractions, microsomes exhibited the highest capability to catalyze CoASH-dependent metabolism of SVA on a per mg protein basis, whereas cytosol was totally incapable of catalyzing the reaction ( Figures 2C and   7C ). As illustrated in Figures 2B and 6B , incubations of SVA with mouse liver microsomes produced significantly higher levels of SVA-CoA and P1-CoA thioesters (approximately 5 to 7 fold higher after 20 min incubations) than that of mouse liver S0.6.
Consistently, the lactonization products, simvastatin and M1, were also found to be This article has not been copyedited and formatted. The final version may differ from this version. approximately 5 to 7 fold higher after 1-hr incubations with mouse liver microsomes than the corresponding incubations with S0.6. These results provided additional support for the acyl-CoA thioester-dependent mechanism proposed previously for the lactonization of the hydroxy acid forms of statins observed in vivo (Duggan and Vickers, 1990) .
Interestingly, P1 levels in microsomes were not significantly more than in S0.6.
Due to the apparent subsequent metabolism of SVA-CoA in mouse liver preparations, the sum of the five metabolites (SVA-CoA, P1-CoA , P1, M1, and simvastatin) was used to compare the rates of CoASH-dependent metabolism of SVA in mouse liver subcellular fractions. Preliminary studies showed that CoASH-dependent metabolism of SVA was linear with time up to 30 min and with mouse liver S0.6 up to 3 mg/mL. As shown in Figure 7C and Table 3 This article has not been copyedited and formatted. The final version may differ from this version. As pointed out by Halpin et al. (1993) , β-oxidation of fatty acids requires that hydroxylated intermediates be in the L-configuration, while in the case of statins, both the 4-and 6-hydroxyl groups on the side chain possess the D-configuration required for pharmacological activity (Figure 1 ). An epimerization to L-configuration has been proposed to be an essential step for D-β-hydroxyacyl CoA thioester to enter the β-oxidation cycles (Halpin et al., 1993) mitochondria and cytosol), in addition to microsomes, might contribute significantly to the hydrolysis of P1-CoA, based on the fact that P1 levels were not significantly increased when the corresponding P1-CoA was increased by 5-7 fold in liver microsomes as compared to liver S0.6 ( Figure 6 ). This observation is consistent with the previous reports on the wide subcelluar distribution of acyl-CoA hydrolases (Urrea and Bronfman, 1996 and Garras et al., 1997) .
It is noteworthy that formation of statin acyl-CoA thioesters is not expected to be unique for SVA. Other statin hydroxy acids, including cerivastatin and atorvastatin, which all share the common D,D-dihydroxy acid side chain undergo β-oxidation, and therefore, are anticipated to be able to form the acyl-CoA thioesters. In fact, our preliminary studies with cerivastatin and atorvastatin showed that acyl-CoA thioesters of these statin acids were readily detectable in vitro in mouse liver preparations.
Additionally, consistent with the in vivo observations on the β-oxidation of statins This article has not been copyedited and formatted. The final version may differ from this version. (Reinoso et al., 2002) , species differences in the formation of acyl-CoA thioesters were also observed in our preliminary studies, which showed that acyl-CoA thioesters of statin hydroxy acids, including SVA, cerivastatin and atorvastatin, were detectable only with liver preparations from mice and rats, but not from dogs and humans. However, such marked species differences were not observed in vivo for the formation of statin lactones.
Significant lactone formation was reported to occur in vivo following administration of SVA or cerivastatin to dogs and of cerivastatin and atorvastatin to humans (Vickers et al., 1990; Boberg et al., 1998; Kantola et al., 1998 Kantola et al., , 1999 , in addition to rodents, suggesting that more than one metabolic pathway might contribute to the formation of statin lactones. In fact, recent study showed that acyl glucuronides also mediated the lactone formation (Prueksaritanont et al., 2002a) . Quantitatively, there appears to be differences in the relative contribution of these two metabolic pathways to the lactone formation of different statins in different species. In rodents, acyl-CoA pathway is likely to contribute significantly to the formation of statin lactones based on the fact that β-oxidation of statins has been shown to be a major pathway in these species (Reinoso et al., 2002) .
Conversely, in dogs, acyl glucuronidation appears to play a more important role in the lactonization of statins than acyl-CoA formation; statins have been shown to undergo significant acyl glucuronidation and minimal β-oxidation in vivo in dogs (Vickers et al., 1990; Boberg et al., 1998; Black et al., 1999; Prueksaritanont et al., 2002a) .
Unfortunately, such conclusion could not be readily drawn in humans, due to limited in vivo data. Nevertheless, based on the findings on acyl glucuronidation in human liver preparations in vitro and in animals in vitro and in vivo (Prueksaritanont et al., 2002a) , it
This article has not been copyedited and formatted. The final version may differ from this version. Incubations were carried out at 37°C for 20 min using mouse liver subcellular fractions (1.5 mg/mL) and SVA (100 µM) with 1.2 mM CoASH and 5 mM ATP. Incubations were carried out in triplicate at 37°C using mouse liver subcellular fractions (1.5 mg/mL) and SVA (100 µM) with 1.2 mM CoASH and 5 mM ATP. Values represent means ± SD from triplicate incubations. This article has not been copyedited and formatted. The final version may differ from this version. The calculated values and formulas are based on the fragmentation assigned in Figure 5 . The MS/MS spectra were obtained using a Micromass Q-TOF mass spectrometer (see text for details).
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